BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3052644)

  • 1. Recent studies on perfluorochemical (PFC) emulsion as an oxygen carrier in Japan.
    Mitsuno T; Ohyanagi H; Yokoyama K; Suyama T
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):365-73. PubMed ID: 3052644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Present status of clinical studies of Fluosol-DA (20%) in Japan.
    Mitsuno T; Ohyanagi H
    Int Anesthesiol Clin; 1985; 23(1):169-84. PubMed ID: 3980104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a perfluorochemical emulsion as a blood gas carrier.
    Mitsuno T; Ohyanagi H; Yokoyama K
    Artif Organs; 1984 Feb; 8(1):25-33. PubMed ID: 6422912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. U.S. clinical studies of the treatment of anemia with fluosol-DA 20%.
    Tremper KK; Cullen BF
    Artif Organs; 1984 Feb; 8(1):19-24. PubMed ID: 6367719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%).
    Tremper KK; Lapin R; Levine E; Friedman A; Shoemaker WC
    Crit Care Med; 1980 Dec; 8(12):738-41. PubMed ID: 7449405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental studies on fluosol DA administration in acute pancreatitis.
    Ohyanagi H; Ohashi O; Nakayama S; Yamamoto M; Okumura S; Saitoh Y
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):585-94. PubMed ID: 3179491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients.
    Suyama T; Yokoyama K; Naito R
    Prog Clin Biol Res; 1981; 55():609-28. PubMed ID: 7027272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorocarbon emulsions: methodology to assess efficacy.
    Rosen AL; Sehgal LR; Gould SA; Sehgal H; Dalton L; Rice CL; Moss GS
    Crit Care Med; 1982 Mar; 10(3):149-54. PubMed ID: 7060386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfluorochemical emulsion oxygen transport fluids: a clinical review.
    Tremper KK; Anderson ST
    Annu Rev Med; 1985; 36():309-13. PubMed ID: 3888055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and clinical application of perfluorochemical artificial blood.
    Ohyanagi H; Saitoh Y
    Int J Artif Organs; 1986 Sep; 9(5):363-8. PubMed ID: 3781670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with Fluosol-DA.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Moss GS
    Prog Clin Biol Res; 1983; 122():331-42. PubMed ID: 6878375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The place for using erythrocyte substitutes in hemodilution: fluosol-DA and polymerized pyridoxylated hemoglobin].
    Vigneron C; Labrude P; Dellacherie E
    Ann Fr Anesth Reanim; 1986; 5(3):260-8. PubMed ID: 3535579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red blood cell substitutes and artificial blood.
    Bowman RJ
    Hum Pathol; 1983 Mar; 14(3):218-20. PubMed ID: 6832769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of fluorocarbon emulsions in cancer radiotherapy.
    Guichard M
    Radiother Oncol; 1991; 20 Suppl 1():59-64. PubMed ID: 2020771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfluorocarbon infusion in bleeding patients refusing blood transfusions.
    Waxman K; Tremper KK; Cullen BF; Mason GR
    Arch Surg; 1984 Jun; 119(6):721-4. PubMed ID: 6610401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A perfluorochemical emulsion as an oxygen carrier.
    Yokoyama K; Suyama T; Okamoto H; Watanabe M; Ohyanagi H; Saitoh Y
    Artif Organs; 1984 Feb; 8(1):34-40. PubMed ID: 6703924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of perfluorochemical emulsions in cancer therapy.
    Teicher BA
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):875-82. PubMed ID: 1391527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fluosol-DA infusion on pulmonary vascular permeability in the dog lung.
    Hall JE; Ehrhart IC; Hofman WF
    J Trauma; 1986 May; 26(5):432-7. PubMed ID: 3084806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfluorocarbons as blood substitutes.
    Waxman K
    Ann Emerg Med; 1986 Dec; 15(12):1423-4. PubMed ID: 3777615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oxygen level on the enhancement of tumor response to radiation by perfluorochemical emulsions or a bovine hemoglobin preparation.
    Teicher BA; Herman TS; Hopkins RE; Menon K
    Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):969-74. PubMed ID: 1917627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.